Quantum Biopharma (QNTM) Operating Income (QoQ) (2019 - 2026)

Quantum Biopharma (QNTM) Operating Income (QoQ) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Quantum Biopharma 13.00 Bn 13.00 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -24.98%
Dec 31, 2025 49.27%
Sep 30, 2025 3.61%
Jun 30, 2025 -42.86%
Mar 31, 2025 -62.45%
Dec 31, 2024 49.98%
Sep 30, 2024 -20.96%
Jun 30, 2024 -53.13%
Jun 30, 2021 -229.45%
Sep 30, 2020 -276.79%
Jun 30, 2020 30.15%
Mar 31, 2020 56.68%
Dec 31, 2019 -36.64%
Sep 30, 2019 -41.82%
Jun 30, 2019 -228.17%